Now showing items 1-6 of 6
Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
Background: Impaired glucose tolerance is a risk factor for atherosclerosis in hemodialysis patients and renal transplant recipients. Methods: To check the relationship of impaired glucose tolerance with the other ...
Apolipoprotein A polymorphysm predicts lipoprotein A concentration in renal transplant recipients
Increased serum lipoprotein(a) is an independent risk factor for atherosclerosis in renal transplant recipients. Higher levels may be due to genetic factors, for example, apolipoprotein A isoforms and/or environmental ...
Calcitriol Started in the Donor, Expands the Population of CD4+CD25+ T Cells in Renal Transplant Recipients
Objectives: Alloreactive T cells recognize antigens via direct and indirect pathways. The competency of costimulatory molecules on antigen-presenting cells (APC) is important. An active form of vitamin D (1,25(OH)2D3, ...
Findings of Doppler sonography do not correlate with serum lipoprotein and total homocysteine concentrations in renal transplant recipients
Atherosclerosis may be evaluated by structural or functional changes of the main arteries. We sought to investigate the probable associations of static and dynamic arterial changes with lipoprotein (a) and homocysteine ...
Serum Receptor Activator of Nuclear Factor-? B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients
Serum receptor activator of nuclear factor-? B ligand and osteoprotegrin are mediated to vascular calcification in the general population. Our knowledge is very sparse in hemodialysis and renal transplant patients. Receptor ...
Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste
Objective: Gingival overgrowth is a complication of cyclosporine therapy following organ transplantation. Oral azithromycin is frequently used to treat this complication. This study examined the efficacy of local azithromycin, ...